Skip to main content
. 2022 Jul 1;119(26):458–465. doi: 10.3238/arztebl.m2022.0204

eTable 4. Drugs prescribed*.

Drug/active substance class Share of patients with a prescription in the respective active substance class (n = 285 568) Share of allantidepressant prescriptions (n = 465 992)
Antidepressants: N06A 42.0%
Other antidepressants: N06AX 17.1% 36.9%
Selective serotonin reuptake inhibitors: N06AB 17.7% 32.4%
Non-selective monoamine reuptake inhibitors: N06AA 14.7% 29.4%
Plant-based antidepressants: N06AP 0.8% 0.9%
Monoamine oxidase A inhibitors: N06AG 0.1% 0.3%
Non-selective monoamine oxidase inhibitors: N06AF < 0.1% 0.1%
Homeopathic/anthroposophic antidepressants: N06AH < 0.1% 0.01%
Benzodiazepine derivatives: N05BA 5.8% Not applicable
Antipsychotics: N05A (lithium: N05AN) 11.3% (0.4%) Not applicable
Combination of antidepressants and antipsychotics: N05A and N06A 7.6% Not applicable

*This overview is based on the codes and designations of the Anatomical Therapeutic Chemical Classification system.